Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · DEEPAKNTR

DEEPAKNTR

CommoditiesChemicals & Petrochemicals₹21294 cr market cap
₹1550.00 ▼ -0.83% today As of 19 Nov 2026
52-week low ₹1286.8052-week high ₹1875.90

-16.7% from the 52-week high · +21.5% above the low

Deepak Nitrite Ltd. operates as a chemical manufacturing company, which engages in the manufacture and sale of chemicals. The company is headquartered in Vadodara, Gujarat and currently employs 1,694 full-time employees. The company went IPO on 2010-09-28. The firm's segments include Basic Chemicals, Fine & Speciality Chemicals, Performance Products and Phenolics. The Basic Chemicals segment offers sodium nitrite, sodium nitrate, nitro toluidines, fuel additives, and nitrosyl sulphuric acid. The Fine & Speciality Chemicals segment offers xylidines, oximes, cumidines, and speciality agrochemicals. Its Performance Products include optical brightening agent (OBA) and diamino stilbene disulfonic acid (DASDA). Its Phenolics offers phenol, acetone, cumene, and isopropyl alcohol. The firm's products cater to several industries, such as colorants, petrochemicals, agrochemicals, rubber, pharmaceuticals, paper, textile and detergents. The firm's manufacturing facilities are located at Nandesari, Dahej (Gujarat), Roha, Taloja (Maharashtra) and Hyderabad (Telangana), and its research and development facility is located at Nandesari (Gujarat).

The short version. DEEPAKNTR reported revenue of ₹3,076 crore for Sep 2026, up 61.7% from a year earlier. Net profit was ₹398 crore (up 234.5% year on year). Return on equity was 9.4% in Mar 2026. Promoter holding was 49.39% in Sep 2026, up 0.15 points over 8 quarters.

1 · The price

How has the stock traded?

DEEPAKNTR trades 16.7% below its 52-week high and 21.5% above its 52-week low.

Change over period: —

1M+0.8%
3M-11.6%
6M-14.3%
1Y-8.4%

2 · The business

Is it growing?

Sales, year on year+61.7%

Sep 2026 revenue of ₹3,076 cr.

Profit, year on year+234.5%

Sep 2026 net profit of ₹398 cr.

Net margin12.9%

6.7 pts higher than a year earlier.

3-year growth-13.6% profit

Revenue compounded at -0.3% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue30762578212019751902189021801903
Net profit39834522010011911220298
Net margin %12.913.410.45.16.25.99.35.2
EPS (₹)29.1625.316.117.328.78.2314.847.19

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue78878282768279726802436042302700
Net profit5516978118521067776611174
Net margin %7.08.410.610.715.717.814.46.4
EPS (₹)40.3651.1259.4562.4778.256.8844.812.73

3 · The quality

How well does it turn capital into profit?

Return on equity was 9.4% in Mar 2026; debt to equity is 0.26.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %9.412.916.920.8
Return on capital %10.814.421.027.0
EBITDA margin %12.914.116.516.7
Net margin %6.98.310.410.6

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR-0.3%12.7%
Profit CAGR-13.6%-6.6%
Debt to equity0.26
Interest cover17.5x
Current ratio2.40
P/E ratio20.3

4 · The owners

Who holds it, and are they adding?

Promoter holding49.39%

Up 0.15 pts over 8 quarters.

Foreign institutions6.4%

Down 0.2 pts over 8 quarters.

Domestic institutions22.5%

Down 0.72 pts over 8 quarters.

Mutual fund schemes84

+13 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter49.2449.2849.2849.2849.3349.3349.3449.39+0.15
FII6.66.656.686.216.056.196.256.4-0.2
DII23.2223.2222.6222.723.223.4723.7622.5-0.72
Public20.9420.8521.4221.8121.4221.0120.6521.71+0.77

Mutual fund holdings · Oct 2026

84 schemes hold this stock

71 the month before.

  • SBI Long Term Advantage Fund - Series VI4.48% of NAV
  • Kotak Nifty Chemicals ETF3.15% of NAV
  • Groww Nifty Chemicals ETF3.15% of NAV
  • Invesco India Nifty Chemical Index Fund3.09% of NAV
  • SBI Comma Fund1.97% of NAV
  • Nippon India Active Momentum Fund1.88% of NAV
  • Franklin India Small Cap Fund1.87% of NAV
  • Franklin India Mid Cap Fund1.44% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for DEEPAKNTR are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about DEEPAKNTR

What is the DEEPAKNTR share price?

DEEPAKNTR (DEEPAKNTR) last closed at ₹1,550.00, down 0.83% on the day. Its 52-week range is ₹1,286.80 to ₹1,875.90.

What is the market cap of DEEPAKNTR?

DEEPAKNTR has a market capitalisation of about ₹21,294 crore. Its price-to-earnings ratio is 20.3.

How are DEEPAKNTR's latest results?

DEEPAKNTR reported revenue of ₹3,076 crore for Sep 2026, up 61.7% from a year earlier. Net profit was ₹398 crore (up 234.5% year on year). Return on equity was 9.4% in Mar 2026. Promoter holding was 49.39% in Sep 2026, up 0.15 points over 8 quarters.

Who owns DEEPAKNTR?

As of Sep 2026, shareholding was: Promoter 49.39%, FII 6.4%, DII 22.5%, Public 21.71%.

How many mutual funds hold DEEPAKNTR?

84 mutual fund schemes held DEEPAKNTR in October 2026. That compares with 71 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 04 Aug 2025 · Dividend - Rs. 7.5
  • 29 Jul 2024 · Dividend - Rs. 7.5
  • 27 Jul 2023 · Final Dividend - Rs. 7.5
  • 25 Jul 2022 · Dividend - Rs. 7
  • 20 Jul 2021 · Dividend - Rs. 4.5
  • 20 Jul 2021 · Special Dividend - Rs. 1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.